Savia de Souza1, Eva C Johansson2, Susanne Karlfeldt3, Karim Raza4, Ruth Williams5. 1. Centre for Rheumatic Diseases, King's College London, London, SE5 9RJ, UK. savia.desouza@outlook.com. 2. Swedish Rheumatism Association (Reumatikerförbundet), Box 90337, 120 25, Stockholm, Sweden. 3. Rheumatology Unit, Karolinska Institutet and Academic Specialist Center, Stockholm Health Services, 171 77, Stockholm, Sweden. 4. Institute of Inflammation and Ageing, University of Birmingham, Birmingham, B15 2WB, UK. 5. Centre for Rheumatic Diseases, King's College London, London, SE5 9RJ, UK.
Abstract
BACKGROUND: Rheuma Tolerance for Cure (RTCure) is a five-year international collaboration between academia, industry and patients/members of the public. It focuses on developing approaches to predict the onset of rheumatoid arthritis (RA) and designing clinical trials to reduce the risk of disease development through immune-tolerising and other treatments. We conducted a mid-term evaluation of patient and public involvement (PPI) within the project. METHODS: Two surveys on PPI were co-designed by the PPI Coordinator, Patient/Public Research Partners (PRPs) and a researcher. Both anonymous, electronic surveys were distributed to 61 researchers and 9 PRPs. Quantitative survey data were analysed using descriptive statistics and free text responses underwent inductive thematic analysis. RESULTS: Researcher and Patient response rates were 33% and 78%, respectively. Quantitative Researcher Survey data highlighted that (i) responding researchers represented all seven Work Packages (WPs), (ii) 40% thought PRPs had made a large or extremely large contribution to their own WPs, (iii) 55% thought PPI has had a moderate or large impact on RTCure, (iv) 75% worked with PRPs in RTCure, and (v) 60% said PRPs had affected their research thinking. Quantitative PRP Survey data highlighted that (i) PRPs were most involved in four WPs, (ii) 43% thought they had made a minor contribution to their main WP, (iii) 57% thought PPI has had a small impact on RTCure, and (iv) 57% thought they received too little feedback on the outcome of their contribution to different tasks. Four main themes were identified in both surveys: 'PRP contributions', 'Experiences of PPI', 'Impact of PPI on RTCure', and 'How PPI can be improved'. Two additional themes from the Researcher Survey were 'Impact of PPI on researchers' and 'Influence on Future Projects', and from the PRP Survey were 'Impact of PPI on PRPs' and 'Engagement with PRPs'. CONCLUSION: PPI seemed to have a significant impact on RTCure, however, PRPs were less aware. A focus on improving communication between PRPs and researchers (facilitated by the PPI Coordinator), and providing PPI training for researchers is likely to improve involvement. Complex legal agreements for PRPs should be avoided and careful attention paid to appropriate PRP compensation.
BACKGROUND: Rheuma Tolerance for Cure (RTCure) is a five-year international collaboration between academia, industry and patients/members of the public. It focuses on developing approaches to predict the onset of rheumatoid arthritis (RA) and designing clinical trials to reduce the risk of disease development through immune-tolerising and other treatments. We conducted a mid-term evaluation of patient and public involvement (PPI) within the project. METHODS: Two surveys on PPI were co-designed by the PPI Coordinator, Patient/Public Research Partners (PRPs) and a researcher. Both anonymous, electronic surveys were distributed to 61 researchers and 9 PRPs. Quantitative survey data were analysed using descriptive statistics and free text responses underwent inductive thematic analysis. RESULTS: Researcher and Patient response rates were 33% and 78%, respectively. Quantitative Researcher Survey data highlighted that (i) responding researchers represented all seven Work Packages (WPs), (ii) 40% thought PRPs had made a large or extremely large contribution to their own WPs, (iii) 55% thought PPI has had a moderate or large impact on RTCure, (iv) 75% worked with PRPs in RTCure, and (v) 60% said PRPs had affected their research thinking. Quantitative PRP Survey data highlighted that (i) PRPs were most involved in four WPs, (ii) 43% thought they had made a minor contribution to their main WP, (iii) 57% thought PPI has had a small impact on RTCure, and (iv) 57% thought they received too little feedback on the outcome of their contribution to different tasks. Four main themes were identified in both surveys: 'PRP contributions', 'Experiences of PPI', 'Impact of PPI on RTCure', and 'How PPI can be improved'. Two additional themes from the Researcher Survey were 'Impact of PPI on researchers' and 'Influence on Future Projects', and from the PRP Survey were 'Impact of PPI on PRPs' and 'Engagement with PRPs'. CONCLUSION: PPI seemed to have a significant impact on RTCure, however, PRPs were less aware. A focus on improving communication between PRPs and researchers (facilitated by the PPI Coordinator), and providing PPI training for researchers is likely to improve involvement. Complex legal agreements for PRPs should be avoided and careful attention paid to appropriate PRP compensation.
Authors: John R Kirwan; Maarten P T de Wit; Clifton O Bingham; Amye Leong; Pamela Richards; Peter Tugwell; Marieke Voshaar; Laure Gossec Journal: Arthritis Rheumatol Date: 2016-06 Impact factor: 10.995
Authors: Carole Mockford; Sophie Staniszewska; Frances Griffiths; Sandra Herron-Marx Journal: Int J Qual Health Care Date: 2011-11-22 Impact factor: 2.038
Authors: Jonathan C Hill; Sujin Kang; Elena Benedetto; Helen Myers; Steven Blackburn; Stephanie Smith; Kate M Dunn; Elaine Hay; Jonathan Rees; David Beard; Sion Glyn-Jones; Karen Barker; Benjamin Ellis; Ray Fitzpatrick; Andrew Price Journal: BMJ Open Date: 2016-08-05 Impact factor: 2.692
Authors: Steven Blackburn; Sarah McLachlan; Sue Jowett; Philip Kinghorn; Paramjit Gill; Adele Higginbottom; Carol Rhodes; Fiona Stevenson; Clare Jinks Journal: Res Involv Engagem Date: 2018-05-24
Authors: Sarah Hewlett; Celia Almeida; Nicholas Ambler; Peter S Blair; Ernest H Choy; Emma Dures; Alison Hammond; William Hollingworth; Bryar Kadir; John Richard Kirwan; Zoe Plummer; Clive Rooke; Joanna Thorn; Nicholas Turner; Jon Pollock Journal: Ann Rheum Dis Date: 2019-02-06 Impact factor: 19.103